Very low-density lipoprotein and the human health

Figure 1 Cushing’s syndrome and very low-density lipoprotein dyslipidemia. FFAS: Free fatty acids; VLDL: Very low-density lipoprotein; LDL-C: Low-density lipoprotein cholesterol.

Figure 2 Effect of glucocorticoid hormones in muscle and adipose tissue. GSK-3: Glycogen synthase kinase 3; GLUT-4: Glucose transporter 4.

Figure 3 Very low-density lipoprotein induced signals mediating aldosterone. VLDL: Very low-density lipoprotein; PLC: Phospholipase C; IP3: Inositol 1,4,5-trisphosphate; PKC: Protein kinase C.

Figure 4 Effect of estrogen and progesterone therapy on very low-density lipoprotein metabolism. VLDL: Very low-density lipoprotein; LPL: Lipoprotein lipase.